208 related articles for article (PubMed ID: 19250671)
21. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
23. Tuberin regulates the DNA repair enzyme OGG1.
Habib SL; Riley DJ; Mahimainathan L; Bhandari B; Choudhury GG; Abboud HE
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F281-90. PubMed ID: 17989114
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P
Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429
[TBL] [Abstract][Full Text] [Related]
25. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Younan S; Elhoseiny S; Hammam A; Gawdat R; El-Wakil M; Fawzy M
Leuk Res; 2012 Feb; 36(2):169-73. PubMed ID: 21978468
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
Qin Y; Zhu H; Jiang B; Li J; Lu X; Li L; Ruan G; Liu Y; Chen S; Huang X
Leuk Res; 2009 Mar; 33(3):384-90. PubMed ID: 18950857
[TBL] [Abstract][Full Text] [Related]
27. The cell cycle and tuberous sclerosis.
Hengstschläger M; Rosner M
Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.
Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN
BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
Niu J; Li H; Zhang Y; Li J; Xie M; Li L; Qin X; Qin Y; Guo X; Jiang Q; Liu Y; Chen S; Huang X; Han W; Ruan G
Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207
[TBL] [Abstract][Full Text] [Related]
30. The expression of iASPP in acute leukemias.
Zhang X; Wang M; Zhou C; Chen S; Wang J
Leuk Res; 2005 Feb; 29(2):179-83. PubMed ID: 15607367
[TBL] [Abstract][Full Text] [Related]
31. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of Wnt molecules in leukemic cells from Iranian patients with acute myeloblastic leukemia.
Memarian A; Jeddi Tehrani M; Vossough P; Sharifian RA; Rabbani H; Shokri F
Iran J Immunol; 2007 Sep; 4(3):145-54. PubMed ID: 17767013
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of a rat homologue of the human tuberous sclerosis 1 gene (Tsc1) and analysis of its mutations in rat renal carcinomas.
Satake N; Kobayashi T; Kobayashi E; Izumi K; Hino O
Cancer Res; 1999 Feb; 59(4):849-55. PubMed ID: 10029074
[TBL] [Abstract][Full Text] [Related]
34. Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
Lugnier C; Majores M; Fassunke J; Pernhorst K; Niehusmann P; Simon M; Nellist M; Schoch S; Becker A
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1136-46. PubMed ID: 19918125
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.
Nellist M; Burgers PC; van den Ouweland AM; Halley DJ; Luider TM
Biochem Biophys Res Commun; 2005 Aug; 333(3):818-26. PubMed ID: 15963462
[TBL] [Abstract][Full Text] [Related]
36. Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway.
Jiang X; Yeung RS
Cancer Res; 2006 May; 66(10):5258-69. PubMed ID: 16707451
[TBL] [Abstract][Full Text] [Related]
37. Management of epilepsy in tuberous sclerosis complex.
Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
[TBL] [Abstract][Full Text] [Related]
38. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
Jansen FE; Braams O; Vincken KL; Algra A; Anbeek P; Jennekens-Schinkel A; Halley D; Zonnenberg BA; van den Ouweland A; van Huffelen AC; van Nieuwenhuizen O; Nellist M
Neurology; 2008 Mar; 70(12):908-15. PubMed ID: 18032745
[TBL] [Abstract][Full Text] [Related]
39. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
40. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.
Devlin LA; Shepherd CH; Crawford H; Morrison PJ
Dev Med Child Neurol; 2006 Jun; 48(6):495-9. PubMed ID: 16700943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]